# Safety and Tolerability Study of MSC Exosome Ointment

> **NCT05523011** · PHASE1 · COMPLETED · sponsor: **Paracrine Therapeutics Dermatology Pte. Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Exosome ointment

## Key facts

- **NCT ID:** NCT05523011
- **Lead sponsor:** Paracrine Therapeutics Dermatology Pte. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-08
- **Primary completion:** 2022-04-05
- **Final completion:** 2022-04-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05523011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05523011, "Safety and Tolerability Study of MSC Exosome Ointment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05523011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*